Quoting Henning Willers, the Director of the Thoracic Radiation Oncology Program, Radiation Biology and Research Program at Mass General Cancer Center, on Twitter:
”Large cohort of lung cancer patients with EGFR mut tumors who received radiotherapy + osimertinib. Risk of pneumonitis seems real. Tight lung metrics + holding TKI for duration of radiation course are important IMO.”
For the article click here.
Source: Henning Willers/Twitter